Drug Shortage Report for IMIPENEM AND CILASTATIN FOR INJECTION
Report ID | 2148 |
Drug Identification Number | 02357437 |
Brand name | IMIPENEM AND CILASTATIN FOR INJECTION |
Common or Proper name | Imipenem and Cilastatin |
Company Name | PFIZER CANADA ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | CILASTATIN IMIPENEM |
Strength(s) | 500MG 500MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 500mg x 10 |
ATC code | J01DH |
ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2016-04-02 |
Estimated end date | |
Actual end date | 2018-08-14 |
Shortage status | Resolved |
Updated date | 2018-08-15 |
Company comments | The drug has been discontinued. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2018-08-15 | English | Compare |
v4 | 2018-08-14 | French | Compare |
v3 | 2018-08-14 | English | Compare |
v2 | 2017-03-14 | French | Compare |
v1 | 2017-03-14 | English | Compare |
Showing 1 to 5 of 5